Innovative Strategies for Selective Inhibition of Histone Deacetylases

Alex Ramalak Maolanon; Andreas Stahl Madsen; Christian Adam Olsen

doi:10.1016/j.chembiol.2016.06.011

Innovative Strategies for Selective Inhibition of Histone Deacetylases

Alex Ramalak Maolanon, Andreas Stahl Madsen, Christian Adam Olsen

36 Citations (Scopus)

Abstract

Histone deacetylases (HDAC) are a family of closely related enzymes involved in epigenetic and posttranscriptional regulation of numerous genes and proteins. Their deregulation is associated with a number of diseases, and a handful of HDAC inhibitors have been approved for cancer treatment. None of these entities, however, exhibit selectivity for a specific human HDAC. Recent structural insights into human HDACs may provide new strategies to achieve selectivity. In this Perspective, we discuss the binding modes of various HDAC inhibitors and highlight topological differences between enzymes as well as key, functionally important, features. Based on this analysis, we suggest alternative strategies to achieve selective HDAC inhibition that does not rely on chelation of the zinc ion in the active site but rather on disruption of protein-protein interactions important for HDAC activity. We believe that, although technically more challenging, these strategies will yield selective small-molecule HDAC modulators for use in basic research and in clinic.

Original language	Danish
Journal	Cell Chemical Biology
Volume	23
Issue number	7
Pages (from-to)	759-768
Number of pages	10
ISSN	1074-5521
DOIs	https://doi.org/10.1016/j.chembiol.2016.06.011
Publication status	Published - 21 Jul 2016

Access to Document

10.1016/j.chembiol.2016.06.011

Cite this

@article{4e644af903f74ecbb2ceb9c0b0082795,

title = "Innovative Strategies for Selective Inhibition of Histone Deacetylases",

abstract = "Histone deacetylases (HDAC) are a family of closely related enzymes involved in epigenetic and posttranscriptional regulation of numerous genes and proteins. Their deregulation is associated with a number of diseases, and a handful of HDAC inhibitors have been approved for cancer treatment. None of these entities, however, exhibit selectivity for a specific human HDAC. Recent structural insights into human HDACs may provide new strategies to achieve selectivity. In this Perspective, we discuss the binding modes of various HDAC inhibitors and highlight topological differences between enzymes as well as key, functionally important, features. Based on this analysis, we suggest alternative strategies to achieve selective HDAC inhibition that does not rely on chelation of the zinc ion in the active site but rather on disruption of protein-protein interactions important for HDAC activity. We believe that, although technically more challenging, these strategies will yield selective small-molecule HDAC modulators for use in basic research and in clinic.",

author = "Maolanon, {Alex Ramalak} and Madsen, {Andreas Stahl} and Olsen, {Christian Adam}",

year = "2016",

month = jul,

day = "21",

doi = "10.1016/j.chembiol.2016.06.011",

language = "Dansk",

volume = "23",

pages = "759--768",

journal = "Chemistry and Biology",

issn = "2451-9448",

publisher = "Elsevier",

number = "7",

}

TY - JOUR

T1 - Innovative Strategies for Selective Inhibition of Histone Deacetylases

AU - Maolanon, Alex Ramalak

AU - Madsen, Andreas Stahl

AU - Olsen, Christian Adam

PY - 2016/7/21

Y1 - 2016/7/21

N2 - Histone deacetylases (HDAC) are a family of closely related enzymes involved in epigenetic and posttranscriptional regulation of numerous genes and proteins. Their deregulation is associated with a number of diseases, and a handful of HDAC inhibitors have been approved for cancer treatment. None of these entities, however, exhibit selectivity for a specific human HDAC. Recent structural insights into human HDACs may provide new strategies to achieve selectivity. In this Perspective, we discuss the binding modes of various HDAC inhibitors and highlight topological differences between enzymes as well as key, functionally important, features. Based on this analysis, we suggest alternative strategies to achieve selective HDAC inhibition that does not rely on chelation of the zinc ion in the active site but rather on disruption of protein-protein interactions important for HDAC activity. We believe that, although technically more challenging, these strategies will yield selective small-molecule HDAC modulators for use in basic research and in clinic.

AB - Histone deacetylases (HDAC) are a family of closely related enzymes involved in epigenetic and posttranscriptional regulation of numerous genes and proteins. Their deregulation is associated with a number of diseases, and a handful of HDAC inhibitors have been approved for cancer treatment. None of these entities, however, exhibit selectivity for a specific human HDAC. Recent structural insights into human HDACs may provide new strategies to achieve selectivity. In this Perspective, we discuss the binding modes of various HDAC inhibitors and highlight topological differences between enzymes as well as key, functionally important, features. Based on this analysis, we suggest alternative strategies to achieve selective HDAC inhibition that does not rely on chelation of the zinc ion in the active site but rather on disruption of protein-protein interactions important for HDAC activity. We believe that, although technically more challenging, these strategies will yield selective small-molecule HDAC modulators for use in basic research and in clinic.

U2 - 10.1016/j.chembiol.2016.06.011

DO - 10.1016/j.chembiol.2016.06.011

M3 - Tidsskriftartikel

C2 - 27447046

SN - 2451-9448

VL - 23

SP - 759

EP - 768

JO - Chemistry and Biology

JF - Chemistry and Biology

IS - 7

ER -